Main Menu

A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.

PMSsmA newer trend in the medical field to help women with  severe PMS or PMDD (premenstrual dysphoric disorder) is the use of pharmaceuticals.  The class of drugs used are antidepressants and SSRI’s.  This study indicates there are other options such as nutrients and balanced diet to help these symptoms.

Severe premenstrual syndrome (PMS) and, more recently, premenstrual dysphoric disorder (PMDD) have been studied extensively over the last 20 years. The defining criteria for diagnosis of the disorders according to the American College of Obstetricians and Gynecologists (ACOG) include at least one moderate to severe mood symptom and one physical symptom for the diagnosis of PMS and by DSM IV criteria a total of 5 symptoms with 1 severe mood symptom for the diagnosis of PMDD. There must be functional impairment attributed to the symptoms. The symptoms must be present for one to two weeks premenstrually with relief by day 4 of menses and should be documented prospectively for at least two cycles using a daily rating form. Nonpharmacologic management with some evidence for efficacy include cognitive behavioral relaxation therapy, aerobic exercise, as well as calcium, magnesium, vitamin B(6) L-tryptophan supplementation or a complex carbohydrate drink.

Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:39-53.

No comments yet.

Leave a Reply